Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine.
Source: hempgazette.com
Stay updated with breaking news from Pharmacist Only. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine.
The right decision on pain relief will provide what you need, and reduce the risk of accidentally taking...
The right decision on pain relief will provide what you need, and reduce the risk of accidentally taking...
The right decision on pain relief will provide what you need, and reduce the risk of accidentally taking...
The right decision on pain relief will provide what you need, and reduce the risk of accidentally taking...